Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Neuropharmacology. 2013 May 6;76(0 0):10.1016/j.neuropharm.2013.04.030. doi: 10.1016/j.neuropharm.2013.04.030

Figure 4. Dorsal mPFC dopamine D1-family receptors mediate yohimbine-induced reinstatement of food seeking.

Figure 4

(A) Systemic SCH23390 (0.01 mg/kg) injections block yohimbine-induced reinstatement; data are mean±sem number of active lever presses during the reinstatement tests. (B) Systemic SCH23390 (0.01 mg/kg) injections block yohimbine-induced Fos expression in dorsal mPFC; data are mean±sem Fos immunoreactive neurons per mm2. (C) Dorsal mPFC SCH23390 injections (0.5 or 1.0 μg/side) decrease yohimbine-induced reinstatement; data are mean±sem number of active lever presses during the reinstatement tests. * Different from the SCH 23390 vehicle condition, p <0.05. Data are based on results from Nair et al. (2011).